Humor en el juego de los reyes: la Torre de la mirada sesgada de la piezas de ajedrez de Lewis

The cultural turn of the twentieth century’s last quarter gradually led to a new approach to the classical objects of historical research. Historians nowadays are required to take on a 'cultural perspective' in the course of their studies. Using the example of a particular piece of the Lewis Chessmen this paper examines both the benefits and the limitations that come about with the cultural approach and cautions against a too rigid application.A Virada Cultural do ultimo quarto do século XX levou, gradualmente, a novas abordagens dos objetos de pesquisa clássicos. Atualmente, historiadores precisam levar em consideração uma "perspectiva cultural" no decorrer de seus estudos. Usando como exemplo uma peça específica do xadrez de Lewis, este artigo examinará tanto os benefícios como as limitações que advém da abordagem cultural, bem como as cautelas tomadas contra uma aplicação muito rígida

Humour in the Game of Kings: The Sideways Glancing Warder of the Lewis Chessmen

The cultural turn of the twentieth century's last quarter gradually led to a new approach to the classical objects of historical research. Historians nowadays are required to take on a 'cultural perspective' in the course of their studies. Using the example of a particular piece of the Lewis Chessmen this paper examines both the benefits and the limitations that come about with the cultural approach and cautions against a too rigid application.A Virada Cultural do ultimo quarto do século XX levou, gradualmente, a novas abordagens dos objetos de pesquisa clássicos. Atualmente, historiadores precisam levar em consideração uma "perspectiva cultural" no decorrer de seus estudos. Usando como exemplo uma peça específica do xadrez de Lewis, este artigo examinará tanto os benefícios como as limitações que advém da abordagem cultural, bem como as cautelas tomadas contra uma aplicação muito rígida

A prospective evaluation of early detection biomarkers for ovarian cancer in the European EPIC cohort

Purpose: About 60% of ovarian cancers are diagnosed at late stage, when 5-year survival is less than 30% in contrast to 90% for local disease. This has prompted search for early detection biomarkers. For initial testing, specimens taken months or years before ovarian cancer diagnosis are the best source of information to evaluate earlydetection biomarkers. Here we evaluate the most promising ovarian cancer screening biomarkers in prospectively collected samples from the European Prospective Investigation into Cancer and Nutrition study. Experimental Design: We measured CA125, HE4, CA72.4, and CA15.3 in 810 invasive epithelial ovarian cancer cases and 1,939 controls. We calculated the sensitivity at 95% and 98% specificity as well as area under the receiver operator curve (C-statistic) for each marker individually and in combination. In addition, we evaluated marker performance by stage at diagnosis and time between blood draw and diagnosis. Results: We observed the best discrimination between cases and controls within 6 months of diagnosis for CA125 (C-statistic = 0.92), then HE4 (0.84), CA72.4 (0.77), and CA15.3 (0.73). Marker performance declined with longer time between blood draw and diagnosis and for earlier staged disease. However, assessment of discriminatory ability at early stage was limited by small numbers. Combinations of markers performed modestly, but significantly better than any single marker. Conclusions: CA125 remains the single best marker for the early detection of invasive epithelial ovarian cancer, but can be slightly improved by combining with other markers. Identifying novel markers for ovarian cancer will require studies including larger numbers of early-stage cases. (C) 2016 AACR

Correlates of circulating ovarian cancer early detection markers and their contribution to discrimination of early detection models: results from the EPIC cohort.

BACKGROUND: Ovarian cancer early detection markers CA125, CA15.3, HE4, and CA72.4 vary between healthy women, limiting their utility for screening. METHODS: We evaluated cross-sectional relationships between lifestyle and reproductive factors and these markers among controls (n = 1910) from a nested case-control study in the European Prospective Investigation into Cancer and Nutrition (EPIC). Improvements in discrimination of prediction models adjusting for correlates of the markers were evaluated among postmenopausal women in the nested case-control study (n = 590 cases). Generalized linear models were used to calculate geometric means of CA125, CA15.3, and HE4. CA72.4 above vs. below limit of detection was evaluated using logistic regression. Early detection prediction was modeled using conditional logistic regression. RESULTS: CA125 concentrations were lower, and CA15.3 higher, in post- vs. premenopausal women (p ≤ 0.02). Among postmenopausal women, CA125 was higher among women with higher parity and older age at menopause (ptrend ≤ 0.02), but lower among women reporting oophorectomy, hysterectomy, ever use of estrogen-only hormone therapy, or current smoking (p < 0.01). CA15.3 concentrations were higher among heavier women and in former smokers (p ≤ 0.03). HE4 was higher with older age at blood collection and in current smokers, and inversely associated with OC use duration, parity, and older age at menopause (≤ 0.02). No associations were observed with CA72.4. Adjusting for correlates of the markers in prediction models did not improve the discrimination. CONCLUSIONS: This study provides insights into sources of variation in ovarian cancer early detection markers in healthy women and informs about the utility of individualizing marker cutpoints based on epidemiologic factors

Humour in the Game of Kings: The Sideways Glancing Warder of the Lewis Chessmen

The cultural turn of the twentieth century's last quarter gradually led to a new approach to the classical objects of historical research. Historians nowadays are required to take on a 'cultural perspective' in the course of their studies. Using the example of a particular piece of the Lewis Chessmen this paper examines both the benefits and the limitations that come about with the cultural approach and cautions against a too rigid application.A Virada Cultural do ultimo quarto do século XX levou, gradualmente, a novas abordagens dos objetos de pesquisa clássicos. Atualmente, historiadores precisam levar em consideração uma "perspectiva cultural" no decorrer de seus estudos. Usando como exemplo uma peça específica do xadrez de Lewis, este artigo examinará tanto os benefícios como as limitações que advém da abordagem cultural, bem como as cautelas tomadas contra uma aplicação muito rígida

Humour in the Game of Kings: The Sideways Glancing Warder of the Lewis Chessmen

The cultural turn of the twentieth century’s last quarter gradually led to a new approach to the classical objects of historical research. Historians nowadays are required to take on a 'cultural perspective' in the course of their studies. Using the example of a particular piece of the Lewis Chessmen this paper examines both the benefits and the limitations that come about with the cultural approach and cautions against a too rigid application.A Virada Cultural do ultimo quarto do século XX levou, gradualmente, a novas abordagens dos objetos de pesquisa clássicos. Atualmente, historiadores precisam levar em consideração uma "perspectiva cultural" no decorrer de seus estudos. Usando como exemplo uma peça específica do xadrez de Lewis, este artigo examinará tanto os benefícios como as limitações que advém da abordagem cultural, bem como as cautelas tomadas contra uma aplicação muito rígida

Treatment of acute ischemic stroke in patients with active malignancy: insight from a comprehensive stroke center

Background: Despite the high incidence of acute ischemic stroke (AIS) in cancer patients, there is still no consensus about the safety of recanalization therapies in this cohort. Objectives: In this observational study, our aim was to investigate the bleeding risk after acute recanalization therapy in AIS patients with active malignancy. Methods and Study Design: We retrospectively analyzed observational data of 1016 AIS patients who received intravenous thrombolysis with rtPA (IVT) and/or endovascular therapy (EVT) between January 2017 and December 2020 with a focus on patients with active malignancy. The primary safety endpoint was the occurrence of stroke treatment-related major bleeding events, that is, symptomatic intracranial hemorrhage (SICH) and/or relevant systemic bleeding. The primary efficacy endpoint was neurological improvement during hospital stay (NI). Results: None of the 79 AIS patients with active malignancy suffered from stroke treatment-related systemic bleeding. The increased rate (7.6% versus 4.7%) of SICH after therapy compared to the control group was explained by confounding factors. A total of nine patients with cerebral tumor manifestation received acute stroke therapy, two of them suffered from stroke treatment-related intracranial hemorrhage remote from the tumor, both asymptomatic. The group of patients with active malignancy and the control group showed comparable rates of NI. Conclusion: Recanalization therapy in AIS patients with active malignancy was not associated with a higher risk for stroke treatment-related systemic or intracranial bleeding. IVT and/or EVT can be regarded as a safe therapy option for AIS patients with active malignancy

An epidemiologic risk prediction model for ovarian cancer in Europe: The EPIC study

Background: Ovarian cancer has a high case-fatality ratio, largely due to late diagnosis. Epidemiologic risk prediction models could help identify women at increased risk who may benefit from targeted prevention measures, such as screening or chemopreventive agents. Methods: We built an ovarian cancer risk prediction model with epidemiologic risk factors from 202 206 women in the European Prospective Investigation into Cancer and Nutrition study. Results: Older age at menopause, longer duration of hormone replacement therapy, and higher body mass index were included as increasing ovarian cancer risk, whereas unilateral ovariectomy, longer duration of oral contraceptive use, and higher number of full-term pregnancies were decreasing risk. The discriminatory power (overall concordance index) of this model, as examined with five-fold cross-validation, was 0.64 (95% confidence interval (CI): 0.57, 0.70). The ratio of the expected to observed number of ovarian cancer cases occurring in the first 5 years of follow-up was 0.90 (293 out of 324, 95% CI: 0.81–1.01), in general there was no evidence for miscalibration. Conclusion: Our ovarian cancer risk model containing only epidemiological data showed modest discriminatory power for a Western European population. Future studies should consider adding informative biomarkers to possibly improve the predictive ability of the model

Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation

Immuno-proteomic screening has identified several tumor-associated autoantibodies (AAb) that may have diagnostic capacity for invasive epithelial ovarian cancer, with AAbs to P53 proteins and cancer-testis antigens (CTAGs) as prominent examples. However, the early detection potential of these AAbs has been insufficiently explored in prospective studies. We performed ELISA measurements of AAbs to CTAG1A, CTAG2, P53 and NUDT11 proteins, for 194 patients with ovarian cancer and 705 matched controls from the European EPIC cohort, using serum samples collected up to 36 months prior to diagnosis under usual care. CA125 was measured using electrochemo-luminiscence. Diagnostic discrimination statistics were calculated by strata of lead-time between blood collection and diagnosis. With lead times ≤6 months, ovarian cancer detection sensitivity at 0.98 specificity (SE98) varied from 0.19 [95% CI 0.08-0.40] for CTAG1A, CTAG2 and NUDT1 to 0.23 [0.10-0.44] for P53 (0.33 [0.11-0.68] for high-grade serous tumors). However, at longer lead-times, the ability of these AAb markers to distinguish future ovarian cancer cases from controls declined rapidly; at lead times >1 year, SE98 estimates were close to zero (all invasive cases, range: 0.01-0.11). Compared to CA125 alone, combined logistic regression scores of AAbs and CA125 did not improve detection sensitivity at equal level of specificity. The added value of these selected AAbs as markers for ovarian cancer beyond CA125 for early detection is therefore limited

Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins

There is an urgent need to improve lung cancer risk assessment because current screening criteria miss a large proportion of cases